The p35 signaling pathway was mediated by Cullin-4B to promote cell proliferation and invasion in CRC (Zhong et al., 2021), and was thought to be a potential targeted signaling pathway for the treatment of CRC (Slattery et al., 2019). Here, CUL4B is linked to colorectal carcinoma.